Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain

Derek Ho, Jared Jagdeo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.

Original languageEnglish (US)
Pages (from-to)199-200
Number of pages2
JournalJournal of Drugs in Dermatology
Volume14
Issue number2
StatePublished - Feb 1 2015

Fingerprint

Pruritus
Pain
Therapeutics
Cosmetics
onabotulinumtoxinA

ASJC Scopus subject areas

  • Dermatology

Cite this

Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain. / Ho, Derek; Jagdeo, Jared.

In: Journal of Drugs in Dermatology, Vol. 14, No. 2, 01.02.2015, p. 199-200.

Research output: Contribution to journalArticle

@article{d4a4f7a5e6914f5c84e1d0729a44c15e,
title = "Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain",
abstract = "OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.",
author = "Derek Ho and Jared Jagdeo",
year = "2015",
month = "2",
day = "1",
language = "English (US)",
volume = "14",
pages = "199--200",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "2",

}

TY - JOUR

T1 - Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain

AU - Ho, Derek

AU - Jagdeo, Jared

PY - 2015/2/1

Y1 - 2015/2/1

N2 - OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.

AB - OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.

UR - http://www.scopus.com/inward/record.url?scp=84922466580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922466580&partnerID=8YFLogxK

M3 - Article

C2 - 25689816

AN - SCOPUS:84922466580

VL - 14

SP - 199

EP - 200

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 2

ER -